Author

P H de Mulder

Observed names: P H De Mulder, P. H. De Mulder, P.H. De Mulder, Pieter H De Mulder, Pieter H. De Mulder, Pieter H. de Mulder, Pieter HM de Mulder

Institution: Radboud University Medical Center

Observed institutions: Karolinska University Hospital, Radboud University Nijmegen, University of Oslo, Lund University, Aristotle University of Thessaloniki, Kantonsspital St. Gallen, Institut Gustave Roussy, Radboud University Medical Center, Karolinska Institutet, European Organisation for Research and Treatment of Cancer, Charité – Universitätsmedizin Berlin, Medical Research Council, Stanford University

OpenAlex ID: A5111940929

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.

1997 · A Horwich, D T Sleijfer, et al. · Journal of Clinical Oncology · 328

Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom.

1998 · S D Fosså, S B Kaye, et al. · Journal of Clinical Oncology · 144

Vaccination of Patients With Metastatic Renal Cell Carcinoma With Autologous Dendritic Cells Pulsed With Autologous Tumor Antigens in Combination With Interleukin-2: A Phase 1 Study

2002 · Jeannette C. Oosterwijk-Wakka, Dorien M. Tiemessen, et al. · Journal of Immunotherapy · 98

Intratumoral Administration of Recombinant Human Interleukin 12 in Head and Neck Squamous Cell Carcinoma Patients Elicits a T-Helper 1 Profile in the Locoregional Lymph Nodes

2004 · Carla M. van Herpen, Maaike Looman, et al. · Clinical Cancer Research · 92

PDF

Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication

1994 · Wim H. Kruit, Kees J. Punt, et al. · Cancer · 55

PDF

Pharmacokinetics and immunological aspects of a phase Ib study with intratumoral administration of recombinant human interleukin-12 in patients with head and neck squamous cell carcinoma: a decrease of T-bet in peripheral blood mononuclear cells.

2003 · Carla M Van Herpen, Richard Huijbens, et al. · PubMed · 49

Clinical and Immunopathological Results of a Phase II Study of Perilymphatically Injected Recombinant Interleukin-2 in Locally Far Advanced, Nonpretreated Head and Neck Squamous Cell Carcinoma

1991 · Vera Mattijssen, Pieter H. De Mulder, et al. · Journal of Immunotherapy · 44

A phase II study of sunitinib administered in a continuous daily regimen in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC)

2006 · P. H. De Mulder, J. Roigas, et al. · Journal of Clinical Oncology · 38

Continuous daily administration of sunitinib in patients (pts) with cytokine-refractory metastatic renal cell carcinoma (mRCC): Updated results

2007 · S. Srinivas, J. Roigas, et al. · Journal of Clinical Oncology · 31

Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma

1994 · V. Mattijssen, P.H. De Mulder, et al. · Annals of Oncology · 30

Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activity.

1990 · R J van Klaveren, P H de Mulder, et al. · Gut · 28

PDF

Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism

1992 · R C Van Schie, R G Verstraten, et al. · The Journal of Immunology · 25

Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis

2008 · Ingrid M. Overes, T. Henriëtte Levenga, et al. · Cancer Immunology Immunotherapy · 18

PDF

The chemotherapy of head and neck cancer

1999 · Pieter HM de Mulder · Anti-Cancer Drugs · 14

Human Leukocyte Antigen Expression in Renal Cell Carcinoma Lesions Does Not Predict the Response to Interferon Therapy

1992 · Vera Mattijssen, Jeroen Van Oorselaar, et al. · Journal of Immunotherapy · 13

Carbonic anhydrase IX expression is more predictive than prognostic in breast cancer

2007 · P N Span, J Bussink, et al. · British Journal of Cancer · 8

PDF

4504 ORAL A phase II study of continuous daily administration of sunitinib in patients with cytokine-refractory metastatic renal cell carcinoma (mRCC) – final results

2007 · B. Escudier, S. Srinivas, et al. · European Journal of Cancer Supplements · 5

[Cancer, what is it?].

1996 · P H de Mulder · PubMed · 5

Ondansetron in the prophylaxis of nausea and vomiting induced by cisplatin

1990 · Peter A. van Liessum, Caroline Seynaeve, et al. · European Journal of Cancer and Clinical Oncology · 3

Measurement of success: parameters of efficacy.

1992 · P H de Mulder · Europe PMC (PubMed Central) · 2

Development of quality indicators for non-Hodgkin lymphoma

2007 · L. Wennekes, P. B. Ottevanger, et al. · Journal of Clinical Oncology

[Pathogenesis of tumor metastases].

1995 · D J Ruiter, P H de Mulder, et al. · PubMed

Works count: 22

Citation count: 1,030

H-index: 14

I10-index: 15